使用新的全球指标进行疫苗安全性监测及2000-2015年免疫接种后不良事件报告趋势
研究分析2000至2015年世界卫生组织/联合国儿童基金会联合报告表中免疫接种后不良事件(AEFI)报告数的趋势,计算每10万存活婴儿的AEFI报告率,评估各国是否达到全球疫苗行动计划设定的最低报告率10。全球平均报告率在2015年为每10万存活婴儿549份报告,报告率大于10的国家从2000年的8个(4%)增至2015年的81个(42%)。
要点
- 2015年全球平均AEFI报告率为每10万存活婴儿549份报告。
- 报告率大于10的国家从2000年8个(4%)增至2015年81个(42%)。
- 2015年美洲区60%国家达到每10万存活婴儿至少10份AEFI报告。
核心结论
- 过去十六年全球AEFI报告有所增加,但多数低和中等收入国家仍需加强。
- AEFI报告率可用于基准比较和趋势跟踪,但不提供报告系统质量信息,也不保证国家层面检测和管理疫苗安全问题的能力。
研究设计与样本
- 描述2000至2015年通过世界卫生组织/联合国儿童基金会联合报告表每年报告的AEFI报告数。
- 计算每10万存活婴儿的年AEFI报告数(AEFI报告率),识别达到最低报告率10的世界卫生组织国家(2000年n=191,2015年n=194)。
主要发现
- 报告任何AEFI的国家数从2000年的32个(17%)增至2015年的124个(64%)。
- 2015年全球平均AEFI报告率为每10万存活婴儿549份报告。
- AEFI报告率大于10的国家从2000年的8个(4%)增至2015年的81个(42%)。
- 2015年世界卫生组织各区域中报告率至少为每10万存活婴儿10份AEFI的国家比例:美洲区60%,欧洲区55%,东地中海区43%,西太平洋区33%,东南亚区27%,非洲区21%。
关键数值与推荐
- 全球疫苗行动计划设定的最低AEFI报告率为每10万存活婴儿10份报告,作为功能性AEFI报告系统的替代指标。
临床怎么用
- AEFI报告率可用于基准比较和跟踪随时间的变化趋势。
- AEFI报告率不提供报告系统质量信息,也不保证国家层面检测和管理疫苗安全问题的能力。
局限性
- AEFI报告率不提供报告系统质量信息,也不保证国家层面检测和管理疫苗安全问题的能力。
- 需额外努力以确保和改善每个国家免疫接种安全的数据质量、AEFI报告和监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reporting of adverse events following immunization (AEFI) is a key component for functional vaccine safety monitoring system. The aim of our study is to document trends in the AEFI reporting ratio globally and across the six World Health Organization (WHO) regions. We describe the number of AEFI reports communicated each year through the World Health Organization/United Nations Children's Fund Joint Reporting Form on Immunization from 2000 to 2015. The AEFI reporting ratios (annual AEFI reports per 100,000 surviving infants) were calculated to identify WHO countries (n = 191 in 2000 and n = 194 by 2015) that met a minimal reporting ratio of 10, a target set by the Global Vaccine Action Plan for vaccine safety monitoring as a proxy measure for a functional AEFI reporting system. The number of countries reporting any AEFI fluctuated over time but with progress from 32 (17%) in 2000 to 124 (64%) in 2015. In 2015, the global average AEFI reporting ratio was 549 AEFI reports per 100,000 surviving infants. The number of countries with AEFI reporting ratios greater than 10 increased from 8 (4%) in 2000 to 81 (42%) in 2015. In 2015, 60% of countries in the WHO Region of the Americas reported at least 10 AEFI per 100,000 surviving infants, followed by 55% in European Region, 43% in Eastern Mediterranean Region, 33% in Western Pacific Region, 27% in South-East Asia Region and 21% in African Region. Overall, AEFI reporting has increased over the past sixteen years worldwide, but requires strengthening in a majority of low- and middle- income countries. The AEFI reporting ratio is useful for benchmarking and following trends over time; but does not provide information on the quality of the reporting system and does not guarantee capacity to detect and manage a vaccine safety problem at a national level. Additional efforts are required to ensure and improve data quality, AEFI reporting and surveillance of immunization safety in every country.
引用
- Lei J, Balakrishnan MR, Gidudu JF, et al. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015. Vaccine. 2018. PMID: 29454518. doi:10.1016/j.vaccine.2018.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。